Castlight Health, Inc. (CSLT) Reaches $4.30 After 6.00% Up Move; Financial Counselors Has Lifted Its Analog Devices (ADI) Stake

January 14, 2018 - By Marguerite Chambers

The stock of Castlight Health, Inc. (NYSE:CSLT) is a huge mover today! The stock increased 7.50% or $0.3 during the last trading session, reaching $4.3. About 639,695 shares traded or 96.91% up from the average. Castlight Health, Inc. (NYSE:CSLT) has declined 18.00% since January 14, 2017 and is downtrending. It has underperformed by 34.70% the S&P500.The move comes after 6 months positive chart setup for the $808.51M company. It was reported on Jan, 14 by Barchart.com. We have $4.56 PT which if reached, will make NYSE:CSLT worth $48.51 million more.

Financial Counselors Inc increased Analog Devices Inc (ADI) stake by 14.15% reported in 2017Q3 SEC filing. Financial Counselors Inc acquired 4,228 shares as Analog Devices Inc (ADI)’s stock declined 1.50%. The Financial Counselors Inc holds 34,099 shares with $2.94 million value, up from 29,871 last quarter. Analog Devices Inc now has $33.92B valuation. The stock increased 0.91% or $0.83 during the last trading session, reaching $92.02. About 3.18M shares traded or 27.67% up from the average. Analog Devices, Inc. (NASDAQ:ADI) has risen 45.85% since January 14, 2017 and is uptrending. It has outperformed by 29.15% the S&P500.

Since August 8, 2017, it had 0 buys, and 9 insider sales for $691,365 activity. 28,639 shares were sold by Nolan Mangini Siobhan, worth $104,920 on Wednesday, August 16. $128,555 worth of Castlight Health, Inc. (NYSE:CSLT) was sold by DOYLE JOHN C on Wednesday, August 16. 23,000 shares were sold by Colella Giovanni M., worth $93,296.

Castlight Health, Inc. operates a health benefits platform in the United States. The company has market cap of $808.51 million. The companyÂ’s platform engages employees to make better health decisions and enables employers to communicate and measure their benefit programs. It currently has negative earnings. The Company’s platform also provides real-time insight into employee engagement with benefits and programs enabling employers to monitor and adjust their strategies.

Among 13 analysts covering Castlight Health (NYSE:CSLT), 6 have Buy rating, 1 Sell and 6 Hold. Therefore 46% are positive. Castlight Health had 29 analyst reports since October 9, 2015 according to SRatingsIntel. The stock has “Buy” rating by Stifel Nicolaus on Monday, July 10. Canaccord Genuity maintained Castlight Health, Inc. (NYSE:CSLT) on Monday, September 4 with “Hold” rating. The stock has “Mkt Perform” rating by Leerink Swann on Thursday, November 5. As per Thursday, October 26, the company rating was maintained by Chardan Capital Markets. On Friday, May 12 the stock rating was downgraded by Morgan Stanley to “Underweight”. The stock of Castlight Health, Inc. (NYSE:CSLT) has “Hold” rating given on Thursday, August 3 by Canaccord Genuity. As per Wednesday, November 18, the company rating was initiated by FBR Capital. Raymond James downgraded Castlight Health, Inc. (NYSE:CSLT) on Thursday, January 5 to “Mkt Perform” rating. On Wednesday, May 11 the stock rating was maintained by FBR Capital with “Mkt Perform”. The firm earned “Buy” rating on Thursday, October 26 by Stifel Nicolaus.

Investors sentiment increased to 2.05 in 2017 Q3. Its up 0.36, from 1.69 in 2017Q2. It is positive, as 5 investors sold Castlight Health, Inc. shares while 15 reduced holdings. 11 funds opened positions while 30 raised stakes. 44.86 million shares or 5.99% more from 42.32 million shares in 2017Q2 were reported. Deutsche National Bank Ag accumulated 57,189 shares. Tower Rech Ltd Liability Corp (Trc) owns 634 shares. Connor Clark Lunn Inv Mngmt Ltd accumulated 15,800 shares or 0% of the stock. Citadel Advsr Ltd Liability Corp has invested 0% in Castlight Health, Inc. (NYSE:CSLT). California Public Employees Retirement Sys reported 42,400 shares. Qs Invsts Ltd Liability Company has 0% invested in Castlight Health, Inc. (NYSE:CSLT). Rhumbline Advisers has 0% invested in Castlight Health, Inc. (NYSE:CSLT) for 66,834 shares. Selz Capital Ltd Liability stated it has 0.66% of its portfolio in Castlight Health, Inc. (NYSE:CSLT). Maverick Cap Limited owns 1.74 million shares. Great West Life Assurance Can holds 0% or 6,297 shares in its portfolio. Virtu Fincl Lc holds 0% or 11,584 shares in its portfolio. California State Teachers Retirement Sys has 0% invested in Castlight Health, Inc. (NYSE:CSLT). Bridgeway, a Texas-based fund reported 115,500 shares. Ubs Asset Mngmt Americas has 0% invested in Castlight Health, Inc. (NYSE:CSLT). Voya Investment Mngmt Ltd Liability owns 26,929 shares for 0% of their portfolio.

Analysts await Castlight Health, Inc. (NYSE:CSLT) to report earnings on February, 21. They expect $-0.10 EPS, down 42.86% or $0.03 from last year’s $-0.07 per share. After $-0.09 actual EPS reported by Castlight Health, Inc. for the previous quarter, Wall Street now forecasts 11.11% negative EPS growth.

Financial Counselors Inc decreased Digital Rlty Tr Inc (NYSE:DLR) stake by 13,664 shares to 114,309 valued at $13.53M in 2017Q3. It also reduced Visa Inc (NYSE:V) stake by 5,099 shares and now owns 135,741 shares. Ishares Russell 1000 Growth In (IWF) was reduced too.

Since August 21, 2017, it had 0 insider purchases, and 19 sales for $16.07 million activity. Shares for $917,000 were sold by STATA RAY on Friday, January 5. The insider NOVICH NEIL S sold 9,303 shares worth $785,759. On Tuesday, October 24 the insider CHAMPY JAMES sold $1.13 million. Shares for $366,080 were sold by Henderson Gregory N. on Friday, January 5. The insider SICCHITANO KENTON J sold $1.32 million. Real Peter sold $402,882 worth of stock or 4,505 shares. On Friday, September 1 Hassett Joseph sold $944,824 worth of Analog Devices, Inc. (NASDAQ:ADI) or 11,280 shares.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>